Trusted Second Opinion Partner - Cromwell Hospital

Second Opinion Press

Empower your cancer care with advanced screening, diagnosis, therapy, and monitoring solutions.

Screening

Non-Invasive Cancer Screening for People Without Symptoms

For early cancer detection, think of

TrucheckTM Intelli

Why screen early?

Cancer continues to pose a significant health challenge, with around 4.1 million new cases and 1.8 million deaths annually across Europe, including the UK. Lifestyle changes and other risk factors are expected to drive these numbers even higher in the future.

Our Scientific Approach

scientific-approach-for-screening

Circulating Tumour Cells (CTCs) and their clusters are present in the blood of almost all cancer patients and are undetectable even in seemingly healthy individuals.

Trucheck™ Intelli technology to detect and characterise CTCs has been proven through extensive clinical validations involving more than 40,000 participants.

The test is a paradigm shift in cancer screening, as it does not involve radiation or invasive procedures. It is performed at our world-class laboratory, which meets and exceeds all national and international standards.

How can TrucheckTM Intelli help in early cancer screening?

Circulating Tumour Cells (CTCs) and their clusters are present in the blood of almost all cancer patients and are undetectable even in seemingly healthy individuals.

Trucheck™ Intelli technology is a revolutionary non-invasive blood test that detects and characterises CTCs and has been proven through extensive clinical validations involving more than 40,000 participants.

The test screens for 70 solid organ cancers with high accuracy and is conducted in a state-of-the-art laboratory that meets international standards.

KNOW MORE

Diagnosis

Risk-free, blood-based biopsy

Usual invasive tissue biopsy for cancer diagnosis can be cumbersome, carries risk for a patient, and sometimes is inaccurate too.

Trublood™ offers a risk-free, accurate, and cost-effective alternative to traditional biopsies for detecting solid and brain tumours. It is a safe method that remains effective even when primary or metastatic cancers are undetectable by conventional means, providing crucial diagnostic insights without invasive procedures.

Trublood™ can avoid pain and anxiety related to traditional biopsies with a non-invasive solution to detect colorectal cancer and cancers of the CNS, lung, breast, pancreas, and prostate.

Key Benefits of Trublood ™

  • Totally non-invasive and is ultimately less expensive
  • No hospitalisation
  • No pain, no stitches, and no scars
  • No risk of injury to any organ
  • Provides 'real-time' data and covers all active sites
  • Can be performed as often as necessary
  • Viable even if primary/metastasis is undetectable.
KNOW MORE
blood-based-cancer-biopsy

Therapy Guidance

Get personalised treatment plans

designed just for you, to help you stay strong in your cancer fight.

  • When Dealing with Advanced Cancer Think of

    Exacta™ | Celldx™ | Chemoscale™

    Cancer is a genetic disease. Every human being is different and unique, so is his/her cancer. However, the conventional 'standard of care' approaches are based on population studies, which disregard the unique genetic landscape and complex metabolic dynamics of the tumour. As a result, the patients are at risk of failed therapies or aggressive relapse. It is, thus, imperative that the genetic architecture of the tumour is studied comprehensively before deciding the treatment plan, which has to be personalised to the individual patient and his/her disease.

    Why Choose Datar's Treatment Solutions?

    Datar offers advanced, comprehensive tumour profiling tests that analyse cellular and genetic data to provide personalised and actionable treatment recommendations. These tests ensure that every treatment plan is tailored to your specific cancer profile.

    Here's How

  • Exacta™

    Exacta™ is a comprehensive, in-depth, integrative, cellular, and molecular tumour analysis that parses millions of data points to present actionable vulnerabilities of the tumor for effective treatment strategies.

    KNOW MORE

  • Celldx™

    Celldx™ provides deep genetic analysis of a tumour, offering insights into key alterations that can guide personalized treatment to 'target' only cancer cells in your body without affecting the normal cells or to stimulate or suppress your 'immune system' to help your body fight cancer.

    KNOW MORE

  • Chemoscale™

    Chemoscale™ provides blood-based analysis of tumour cells to guide which chemotherapy drug will work for you and predict resistance to any chemotherapy drug.

    KNOW MORE
monitoring-DNA

Monitoring

Keep a close watch on your progress and catch any changes early with regular monitoring.

 

 

 

 

 

For a safe and non-invasive
cancer diagnosis, think

Cancertrack™

Cancertrack™ is a non-invasive and blood-based test that detects cancer biomarkers with high precision, allowing frequent monitoring of disease progression or recurrence. It eliminates the need for radiation, hospitalisation, anaesthesia, or painful biopsies, providing a safer and more efficient way to track how your cancer responds to therapy and to monitor further progression.
KNOW MORE

cancer-screening

Monitoring